#novo-nordisk

[ follow ]
#ozempic
US news
fromwww.npr.org
2 weeks ago

The FDA warns patients about counterfeit Ozempic that may be in circulation

FDA warns of counterfeit Ozempic affecting patient safety.
Report includes details about counterfeit serial numbers.
Novo Nordisk acknowledges multiple counterfeit incidents.
Miscellaneous
fromFuturism
4 months ago

Dr. Oz Will Have a Fascinating Conflict of Interest Running Medicare: Ozempic

Mehmet Oz's potential role in leading Medicare raises concerns due to his past connections with Novo Nordisk, makers of Ozempic.
Medicine
fromABC7 Los Angeles
3 months ago

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic is FDA approved to reduce risks associated with chronic kidney disease in diabetes patients.
US news
fromwww.npr.org
2 weeks ago

The FDA warns patients about counterfeit Ozempic that may be in circulation

FDA warns of counterfeit Ozempic affecting patient safety.
Report includes details about counterfeit serial numbers.
Novo Nordisk acknowledges multiple counterfeit incidents.
Miscellaneous
fromFuturism
4 months ago

Dr. Oz Will Have a Fascinating Conflict of Interest Running Medicare: Ozempic

Mehmet Oz's potential role in leading Medicare raises concerns due to his past connections with Novo Nordisk, makers of Ozempic.
Medicine
fromABC7 Los Angeles
3 months ago

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic is FDA approved to reduce risks associated with chronic kidney disease in diabetes patients.
more#ozempic
#wegovy
NYC startup
fromwww.nytimes.com
1 month ago

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Novo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
fromFuturism
7 months ago
Medicine

New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
fromFast Company
5 months ago
Medicine

The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?

The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.
Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.
fromwww.theguardian.com
2 months ago
Miscellaneous

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Novo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
fromFortune Europe
5 months ago
Business

Novo Nordisk's Wegovy sales jump on international rollouts

Wegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.
fromwww.mercurynews.com
8 months ago
Medicine

Wegovy reduced COVID deaths in obese patients, study shows

Wegovy significantly reduced deaths and illness from COVID-19 during a large study, showcasing its benefits beyond weight loss.
NYC startup
fromwww.nytimes.com
1 month ago

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Novo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
Medicine
fromFuturism
7 months ago

New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
fromFast Company
5 months ago
Medicine

The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?

The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.
Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.
fromwww.theguardian.com
2 months ago
Miscellaneous

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Novo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
fromFortune Europe
5 months ago
Business

Novo Nordisk's Wegovy sales jump on international rollouts

Wegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.
fromwww.mercurynews.com
8 months ago
Medicine

Wegovy reduced COVID deaths in obese patients, study shows

Wegovy significantly reduced deaths and illness from COVID-19 during a large study, showcasing its benefits beyond weight loss.
more#wegovy
Digital life
fromwww.nytimes.com
2 months ago

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Novo Nordisk reported strong earnings in 2024 but expects slower sales growth in 2025 due to competition.
The company’s share price has fallen dramatically amid uncertainties in the obesity drug market.
#weight-loss-drugs
fromFuturism
7 months ago
Wellness

Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds

Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
fromFast Company
4 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
fromFuturism
7 months ago
Wellness

Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds

Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
fromFast Company
4 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
more#weight-loss-drugs
fromBusiness Insider
4 months ago
Miscellaneous

I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.
fromFortune Europe
7 months ago
Left-wing politics

Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony

Novo Nordisk's weight loss drugs are effective but criticized for their high costs and accessibility issues in the U.S.
Medicine
fromFuturism
7 months ago

Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects

Novo Nordisk's new weight loss drug monlunabant shows promising results but raises concerns due to increased risk of psychiatric side effects compared to placebo.
Medicine
fromBusiness Insider
7 months ago

The next big market for weight-loss drugs: children

Novo Nordisk's Saxenda can significantly reduce children's BMI, showing potential for FDA approval in a market with currently no approved obesity medications for children.
[ Load more ]